about
Conflict of Interest Policies at French Medical Schools: Starting from the BottomAttitudes of medical students towards conflict of interest: a national survey in FranceInteractions between medical residents and drug companies: a national survey after the Mediator® affairPharmaceutical policies in European countries in response to the global financial crisis.And if the discovery of new drugs for the treatment of brain diseases depends on Asian countries?Pharmacovigilance systems in developing countries: an evaluative case study in Burkina Faso.The risks of risk aversion in drug regulation.Market access of cancer drugs in European countries: improving resource allocation.Transparency in Europe: A Quantitative Study.Evolution of pharmacological obesity treatments: focus on adverse side-effect profiles.Regulating Information or Allowing Deception? Pharmaceutical Sales Visits in Canada, France, and the United States.Independent drug bulletins to promote the prescription of appropriate drugs: a necessary but difficult task.A comparative analysis of two contrasting European approaches for rewarding the value added by drugs for cancer: England versus France.Incretins and pancreatitis--what happens next? A personal viewpoint.Marketing Authorization Procedures for Advanced Cancer Drugs: Exploring the Views of Patients, Oncologists, Healthcare Decision Makers, and Citizens in France.Medicines Save, Medicines Kill.Flu vaccination among patients with diabetes: motives, perceptions, trust, and risk culture - a qualitative survey.Conflict of interest in Health Technology Assessment decisions: case law in France and impact on reimbursement decisions.Perceptions of French general practitioners and patients regarding dextropropoxyphene withdrawal: a qualitative studyBenfluorex and Mortality: A Fresh PerspectivePathological Conditions Associated with the Disturbance of the 5-HT System
P2860
Q28468374-BA3195CC-0DC6-4F7D-A512-EE713F5D19C1Q28541567-33DC535C-D3F9-4CB8-9037-C7938CE5E66CQ28543522-16550072-E5D4-440A-A2AE-EF734EC48D33Q34307945-A5A325BD-44F1-4D0A-9CFF-BDE3CBE39E14Q36897714-4D656EE0-ED9E-4EE7-A592-44731184B073Q38098476-508D4B0C-0171-4DD8-A486-107542AC0DEAQ38162718-A364C134-8261-4AFD-9D99-3DB3C701F10BQ38163486-406BC115-4E07-4E84-B597-D75D246C6DC3Q38452513-0993BF36-9A0C-4CDB-9C61-D9C5AB99FF95Q38758765-D7FF735E-7B67-4BFB-9151-AFA196CDD001Q40141397-54AFBFD7-A703-4047-99F4-ECF2968961B0Q42636229-158C05F5-3658-4DC8-B996-6F28A28B2CA8Q44718239-B3EF0CC0-1801-4990-835B-AA9831EF1BDDQ45342248-37DB9DBE-0286-485B-9D88-1B1095A13A44Q47989250-982399E5-85AB-41DC-B7CF-F174877E59B5Q48108788-E05445D8-4880-4C0A-A32A-17E7C6D655D1Q54223818-C9C68B9C-2646-4A91-8B4E-8B304A5A9DABQ54965189-AC7EB5DC-36D7-4207-84FA-07BC6DE771DEQ57152741-BE620FDA-01C3-42EF-B4FB-6F8366901723Q58922689-6ACC2332-5383-408B-9A1E-81B3F5C20968Q59201274-A3C81BB6-31D6-4DB1-81A5-336AA8E9604C
P2860
description
2011 nî lūn-bûn
@nan
2011 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մարտին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Mediator scandal rocks French medical community
@ast
Mediator scandal rocks French medical community
@en
Mediator scandal rocks French medical community
@nl
type
label
Mediator scandal rocks French medical community
@ast
Mediator scandal rocks French medical community
@en
Mediator scandal rocks French medical community
@nl
prefLabel
Mediator scandal rocks French medical community
@ast
Mediator scandal rocks French medical community
@en
Mediator scandal rocks French medical community
@nl
P1433
P1476
Mediator scandal rocks French medical community
@en
P2093
Asher Mullard
P356
10.1016/S0140-6736(11)60334-6
P407
P577
2011-03-12T00:00:00Z